Atlas Trials

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Clinical trial NCT07154914 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07154914
Sponsor
Anhui Medical University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Metastatic Hormone-Sensitive Prostate Cance
Start date
2025-09-01
Primary completion
2026-09-01
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.